Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05219500
Title Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). (TATCIST)
Acronym TATCIST
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fusion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.